November 6, 2015

If you no longer wish to receive this free newsletter, CLICK HERE to unsubscribe
The ValuEngine Weekly is an Investor Education newsletter focused on the quantitative approach to
investing and the tools available from In today's fast-moving and globalized financial markets, it is easy to
get overloaded with information. The winners will adopt an objective, scientific, independent and
unemotional approach to investing. If you are not yet a member of ValuEngine's stock analysis service,
sign up now for a two-week free trial at www.valuengine.com!

VALUATION WATCH: Overvalued stocks now make up 50.49% of our

stocks assigned a valuation and 17.76% of those equities are calculated to
be overvalued by 20% or more. Nine sectors are calculated to be
overvalued--with one overvalued by double digits.
MARKET OVERVIEW
Index

Started week

Friday PM

Change

Change %

ytd

DJIA

17672.62

17841.4

168.78

0.96%

0.10%

NASDAQ

5053.75

5125.61

71.86

1.42%

8.44%

RUSSELL 2000

1161.95

1194.91

32.96

2.84%

-0.81%

S&P 500

2080.76

2091.19

10.43

0.50%

1.57%

Summary of VE Stock Universe

Stocks Undervalued

49.51%

Stocks Overvalued

50.49%

Stocks Undervalued by 20%

21.97%

Stocks Overvalued by 20%

17.76%

SECTOR OVERVIEW
Sector

Change

MTD

YTD

Valuation

Last 12-M
Return

P/E
Ratio

Aerospace

0.17%

1.84%

0.88%

12.82% overvalued

-6.59%

18.41

Auto-Tires-Trucks

-0.27%

1.25%

-3.12%

7.51% undervalued

-5.94%

15.36

Basic Materials

-1.35%

-0.19%

-15.45%

11.96% undervalued

-19.19%

23.24

Business Services

-1.00%

-0.19%

3.48%

3.07% overvalued

-1.86%

23.36

Computer and Technology

-0.27%

1.92%

1.44%

3.34% overvalued

0.61%

28.76

Construction

-0.74%

0.74%

2.45%

3.15% undervalued

-1.78%

20.85

Consumer Discretionary

-0.64%

0.28%

2.34%

3.83% overvalued

-0.52%

26.08

Consumer Staples

-0.05%

0.26%

2.33%

5.87% overvalued

1.83%

24.51

Finance

0.15%

1.04%

1.85%

4.00% overvalued

-1.91%

17.18

Industrial Products

-0.80%

1.18%

-6.18%

3.01% undervalued

-11.73%

20.01

Medical

-0.46%

2.75%

5.24%

4.12% overvalued

3.16%

29.68

Multi-Sector Conglomerates

-0.60%

-0.14%

-8.31%

4.15% overvalued

-7.67%

21.23

Oils-Energy

-0.99%

2.71%

-17.77%

1.71% undervalued

-41.10%

25.96

Retail-Wholesale

0.01%

2.12%

-5.02%

3.36% undervalued

-1.42%

22.64

Transportation

0.01%

0.12%

-11.23%

10.86% undervalued

-15.05%

14.48

Utilities

-1.21%

-0.44%

-4.00%

2.29% overvalued

-7.35%

21.21

Sector TalkAutos/Tires/Trucks
Below, we present the latest data on leading Autos/Tires/Trucks Sector stocks
from our Professional Stock Analysis Service. These results were filtered by market
price and volume--no results below 3$/share or less than 100k shares/day volume.

Top-Five Autos/Tires/Trucks Sector Stocks--Short-Term Forecast Returns

Ticker

Company Name

Market Price

Valuation

Last 12-M Retrn

AXL

AMER AXLE & MFG

22.41

-3.77%

15.93%

GM

GENERAL MOTORS

35.44

-0.18%

12.87%

WNC

WABASH NATIONAL

12.63

5.21%

22.62%

LEA

LEAR CORPORATN

123.38

2.11%

33.38%

TOWR

TOWER INTL INC

27.29

6.43%

12.30%

Top-Five Autos/Tires/Trucks Sector Stocks--Long-Term Forecast Returns

Ticker

Company Name

Market Price

Valuation

Last 12-M Retrn

AXL

AMER AXLE & MFG

22.41

-3.77%

15.93%

GM

GENERAL MOTORS

35.44

-0.18%

12.87%

WNC

WABASH NATIONAL

12.63

5.21%

22.62%

LEA

LEAR CORPORATN

123.38

2.11%

33.38%

TOWR

TOWER INTL INC

27.29

6.43%

12.30%

Top-Five Autos/Tires/Trucks Sector Stocks--Composite Score

Ticker

Company Name

Market Price

Valuation

Last 12-M Retrn

GM

GENERAL MOTORS

35.44

-0.18%

12.87%

FORD MOTOR CO

14.57

-5.81%

3.41%

LEA

LEAR CORPORATN

123.38

2.11%

33.38%

TM

TOYOTA MOTOR CP

124.86

-2.09%

2.89%

AXL

AMER AXLE & MFG

22.41

-3.77%

15.93%

Top-Five Autos/Tires/Trucks Sector Stocks--Most Overvalued

Ticker

Company Name

Market Price

Valuation

Last 12-M Retrn

VC

VISTEON CORP

113.84

58.28%

21.24%

TSLA

TESLA MOTORS

231.77

40.25%

-4.11%

ALV

AUTOLIV INC

126.14

37.59%

37.50%

CTB

COOPER TIRE

42.47

33.76%

31.85%

SMP

STANDARD MOTOR

44.37

26.45%

12.27%

Find out what Wall Street Investment and Media Professionals already know,
ValuEngine offers sophisticated stock valuation and forecast research as well as a
variety of portfolio screening and creation tools.
If you are reading this you
should sign up for
ValuEngine's award-winning To Sign Up for a
stock valuation and forecast FREE TRIAL,
service
Please Click
HERE
NO OBLIGATION, 14 DAY
FREE TRIAL!

Free Download for Readers

As a bonus to our Free Weekly Newsletter subscribers,
we are offering a FREE DOWNLOAD of one of our Stock Reports
Valeant Pharmaceuticals International, Inc. (VRX) is a pharmaceutical
company that develops, manufactures and markets a broad range of
pharmaceutical products primarily in the areas of neurology, dermatology and
branded generics. The Company produces medicines that meet the special health
problems of patients. Valeant's development pipeline strategy comprises both new
compounds as well as product life cycle management. Its early and late-stage drug
candidates have unique formulations and mechanisms of action including retigabine
for the treatment of epilepsy and pain, taribavirin of the treatment of chronic
hepatitis C, and several dermatology candidates for the treatment of rosacea, acne,
and dermatological fungus. Valeant Pharmaceuticals International, Inc. is
headquartered in Mississauga, Canada.
ValuEngine continues its BUY recommendation on VALEANT PHARMA for 201511-05. Based on the information we have gathered and our resulting research, we
feel that VALEANT PHARMA has the probability to OUTPERFORM average market
performance for the next year. The company exhibits ATTRACTIVE P/E Ratio and
Company Size.
NOTE: This stock is "controversial" to say the least. We provide our quant-based analysis so that an
objective view can be seen. Of course, if there are human-driven balance sheet shenanigans going
on here-- as the various short sellers suggest, the computers cannot be aware of it.

Read our Complete Detailed Valuation Report on Valeant Pharmaceuticals HERE.

ValuEngine Forecast
Target
Price*

Expected
Return

1-Month

79.15

0.49%

3-Month

79.05

0.35%

6-Month

78.50

-0.35%

1-Year

83.36

5.82%

2-Year

59.18

-24.87%

3-Year

74.45

-5.48%

Valuation & Rankings

Valuation

63.23% undervalued

Valuation Rank(?)

1-M Forecast Return

0.49%

1-M Forecast Return Rank

97
84

12-M Return

-40.79%

Momentum Rank(?)

Sharpe Ratio

0.54

Sharpe Ratio Rank(?)

5-Y Avg Annual Return

24.45%

5-Y Avg Annual Rtn Rank

Volatility

45.32%

Volatility Rank(?)

Expected EPS Growth

48.71%

EPS Growth Rank(?)

Market Cap (billions)

26.44

Size Rank

96

Trailing P/E Ratio

7.36

Trailing P/E Rank(?)

96

Forward P/E Ratio

4.95

Forward P/E Ratio Rank

PEG Ratio

0.15

PEG Ratio Rank

Price/Sales

2.65

Price/Sales Rank(?)

Market/Book

4.03

Market/Book Rank(?)

Beta

0.66

Beta Rank

Alpha

-0.37

Alpha Rank

19
84
95
39
75

97
81
35
29
60
20

Time-Tested Portfolios From ValuEngine Premium Pro

Selecting investment targets from the thousands of equities out there can be a
difficult task. It becomes even more daunting in times of market volatility and
uncertainty. Thankfully, with ValuEngines Premium Professional Service you can
access ready-made portfolio strategies like our ValuEngine View and ValuEngine
Forecast 16 Market Neutral Portfolio Newslettersavailable only to VE Premium
Professional subscribers.
With the VE Premium Professional Service, you also get access to easy to use
Advanced Screening tools with over 30 criteria based on our rankings for more than
5000 US and foreign stocks, ADRs, and Canadian equities. With VE Premium, all of our
data-points and outputs are easily integrated via Microsoft Excel into your own work
flow. Detailed Stock Valuation and Forecast Reports are also available in addition to
the time-tested newsletter portfolios that can make your job much easier.
And, with VE Premium, the professional's choice, you can quickly and easily
download any of our individual stock, industry, and sector reports for a complete
ValuEngine analysis in an easily analyzed PDF format.
Save your own valuable time and avoid combing through mountains of data.
Sign up for VE Premium Professional Service and get access to every tool in
ValuEngine's award-winning research suite. Act now and pay nothing for 14 days plus,
save up to $200 on your first year with a longer-term membership.
VE PREMIUM IS THE PROFESSIONAL'S CHOICE CLICK HERE TO SUBSCRIBE

ValuEngine.com is an independent research provider, producing

buy/hold/sell recommendations, target price, and valuations on over 7,000
US and Canadian equities every trading day.
Visit www.ValuEngine.com for more information and a free trial.